Regulation of cyclamate sweeteners

28 Hearings 91st Congress abbreviated NDA's anticoagulant artificial sweetener bladder Committee on Government concerning the safety containing cyclamates continued marketing CONVENING THE MEDICAL Cosmetic Act cyclamate orders cyclamate products cyclamate sweeteners cyclamate-containing products cyclamates in food CYCLAMATES REPORTED Delaney clause diabetes or obesity difference of expert difference of opinion drug applications effects of cyclamates establish their safety FDA Commissioner FDA'S CYCLAMATE REGULATIONS FDA's medical staff Federal Food Food Additives Amendment Food and Drug Government Operations GRAS list Group on Cyclamates GUY VANDER JAGT HEW and FDA HEW convened Intergovernmental Relations Subcommittee JENNINGS JOHN marketing of cyclamate marketing of cyclamate-containing Medical Advisory Group Medical supervision NAS-NRC panels NDA approval new-drug application nonprescription drugs October 18 opinion among qualified procedures products as drugs products as nonprescription qualified experts rats recognized as safe recommendations REGULATION OF CYCLAMATE remove cyclamates saccharin safety and effectiveness safety of cyclamates Secretary STANFORD sweeteners and cyclamate-containing THIRTY-SIXTH REPORT